Aegis Life, Inc. announced today that the first participants have been dosed in a Phase 1/2 clinical trial with parent company Entos Pharmaceuticals’ (Entos) Covigenix VAX-001, a novel DNA vaccine to stimulate immunity against SARS-CoV-2.
Latest Press Releases
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
LGC Maine Standards¹ announces a product update for VALIDATE® Diabetes which meets the linearity and calibration verification needs of clinical laboratories running the Roche cobas® platform.
Four months after raising its seed round from Hoxton Ventures and dRX Capital, a venture arm of Novartis Pharma AG, Peptone, the molecular computational physics company focused on protein drug discovery and engineering tools.
In recent weeks, 3B Medical announced the release of its new portable and compact UVC sanitizer, the Lumin Wand, which uses ultraviolet germicidal irradiation (UVGI) to kill 99.9 percent of harmful germs and bacteria in just seconds.
endpoint Clinical, an industry-leading global interactive response technology (IRT) company, has appointed Christine Hurley as its Senior Vice President, Client Services.
CollPlant Biotechnologies (NASDAQ: CLGN) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with Allergan Aesthetics, an AbbVie company.
HealthSTAR Strategic Engagements (HSE) is proud to announce the launch of another in its line of robust integration solutions with Veeva’s CRM and Events Managements product line, HSE’s third unique integration just in the Patient Engagements space.
SkinCeuticals, the #1 medical professional skincare brand in the US, announces the opening of SkinCeuticals SkinLab™ in partnership with Cosmetic Surgery Institute (CSI).
Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company™, announced today a partnership for custom and commercial medias and delivery systems for Cell and Gene Therapy clients.
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that two poster presentations will feature data on the new Bausch + Lomb INFUSE™ silicone hydrogel (SiHy) daily disposable contact lenses during the virtual Global Specialty Lens Symposium (GSLS).